State Ledger
Company profile

Skye Bioscience, Inc. CIK 1516551

Ticker
SKYE (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
San Diego, CA 92130
Fiscal year end
2025 (FY)
Market Data
Close
$1.69
Change
+$0.02
Change %
1.20%
Volume
664

SKYE · trading date Oct 9, 2026 · previous close $1.67 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$55.92M
Total assets
$28.31M
Total liabilities
$8.29M
Stockholders' equity
$20.02M
Cash & equivalents
$5.88M
Operating income
-$58.16M
Operating cash flow
-$43.06M
Capital expenditures
$6.3K

Fiscal year 2025, via 10-K filed 2026-03-10. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$43.07M
Free cash flow margin
—
Liabilities / assets
29.3%
Equity / assets
70.7%
CapEx / revenue
—
Operating cash flow / net income
0.77×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$55.92M $28.31M $8.29M $20.02M
2024 — -$26.57M $72.76M $4.61M $68.15M
2023 — -$37.64M $11.94M $14.07M -$2.13M
2022 — -$19.48M $9.11M $12.12M -$3.01M
2021 — -$8.52M $9.86M $3.99M $5.86M
Company Details
SIC code
2834
State of incorporation
NV
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-18
Financials filed via
Form 10-K
filed 2026-03-10

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
San Diego, CA 92130
11250 EL CAMINO REAL, SUITE 100
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:17 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies